International Journal of Occupational and Environmental Medicine

International Journal of Occupational and Environmental Medicine

International Journal of Occupational and Environmental Medicine

Current Issue Volume No: 1 Issue No: 1

Review Article Open Access Available online freely Peer Reviewed Citation

Effects of Involuntary Smoking and Vaping on the Cardiovascular System

Manfred Neuberger 1  

1Center of Public Health, Medical University of Vienna, Wien, Felbigergasse 3/2/18, Austria

Abstract

In deaths and diseases attributed to tobacco smoke cardiovascular events exceed cancer and respiratory diseases. Second hand smoke promotes the development of arteriosclerosis and can trigger acute changes of endothelial function and blood coagulability. Indoor smoking bans reduced coronary syndrome and myocardial infarction 10-20% within one year and were followed by sustainable decreases of stroke and diabetes. With a smoke-free hospitality industry people recognized tobacco smoke as an air pollutant, smoking in public was denormalized and social acceptance of smoking in front of children and pregnant women decreased also in homes and cars. Combined effects with ambient air pollution are proven for active smoking and suspected for SHS. Contamination with third hand smoke (THS) persists for months in homes and cars, creating secondary pollutants that in some cases are more toxic (e.g. nitrosamines). Remnants found in air, dust, and on surfaces (carpets, wallpapers, upholstery, soft toys) were associated with their metabolites in saliva of children and in urine of nonsmokers residing in homes previously occupied by smokers. In animal experiments effects of THS were found on thrombogenesis, insulin resistance through oxidative stress, on the developing immune system, lipid metabolism and alterations in liver, lung, skin and behavior. Much less is known about health effects for bystanders from the aerosols exhaled during “vaping” of e-cigarettes, but nicotine and other toxins from e-cigarettes are certainly a hazard, which should be prevented by the use of dermal and oral nicotine products, which are safer for nicotine replacement and without risk for bystanders.

Author Contributions
Received 22 Apr 2019; Accepted 15 Jun 2019; Published 18 Jun 2019;

Academic Editor: Dilip Kadam, Assistant Professor, Dept. of Community Medicine, Seth G.S. Medical College & K.E.M. Hospital. Parel, Mumbai, Maharashtra, India.

Checked for plagiarism: Yes

Review by: Single-blind

Copyright ©  2019 Manfred Neuberger

License
Creative Commons License     This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing interests

The authors have declared that no competing interests exist.

Citation:

Manfred Neuberger (2019) Effects of Involuntary Smoking and Vaping on the Cardiovascular System. International Journal of Occupational and Environmental Medicine - 1(1):10-18. https://doi.org/10.14302/issn.2690-0904.ijoe-19-2792

Download as RIS, BibTeX, Text (Include abstract )

DOI 10.14302/issn.2690-0904.ijoe-19-2792

Introduction

Cardiovascular deaths from tobacco use and secondhand smoke (SHS) exceed deaths from cancer and respiratory diseases attributed to tobacco smoke 1, 2, 3. But many smokers are still unaware of the link between tobacco smoke and cardiovascular diseases (CVD), e.g. stroke 4, even in countries like China where many strokes from smoking in men and from SHS in women occur 1, 5, 6. Information on links between tobacco use or exposure on heart attacks, stroke, peripheral vascular disease and impotence is still news for many people and even medical doctors sometimes doubt that SHS causes CVD, because they occur less frequently than in active smokers. Therefore the following expert judgement focuses on CVD from involuntary exposure.

Burden of CVD from SHS

Worldwide, 40% of children, 33% of male non-smokers, and 35% of female non-smokers were exposed to second-hand smoke in 2004 7, This exposure was estimated to have caused 379 000 deaths from ischemic heart disease and a total of 603 000 premature deaths, 47% of which occurred in women, 28% in children, and 26% in men. Disability adjusted life years lost because of exposure to SHS amounted to 10.9 million, of which 61% were in children. The largest disease burdens in adults (2 836 000) were from ischemic heart disease 7 Prospective cohort studies showed high risks of SHS for coronary heart disease 8 and stroke 9, without evidence of a threshold 10. Especially at work places like bars or discotheques, where many smokers release SHS, substantial increases of acute coronary events were found 11, 12. The acute cardiovascular effects of SHS were attributed mainly to the ultrafine particles released from the burning end of cigarettes between puffs 11, 13.

Pathogenesis of CVD from SHS

Chronic inhalation of SHS contributes to development of CVD in healthy persons by oxidative stress and vascular inflammation, while acute effects of SHS are triggering manifestation of CVD in risk groups 11, 14, 15. Toxins distributed on the large surface of ultrafine particles inhaled with SHS elicit acute endothelial dysfunction with inactivation of nitric oxide (mediating vasodilatation), impairment of the viability of endothelial cells and reduction of the number and functional activity of circulating endothelial progenitor cells. In addition, platelets of non-smokers appear to be susceptible to pro-aggregatory changes with every passive smoke exposure. Apart from vasoconstriction and thrombus formation from sticky platelets, increased fibrinogen and other factors of blood coagulation, the myocardial oxygen balance is further impaired by SHS-induced adrenergic stimulation and autonomic dysfunction with heart rhythm disturbances 11, 15, 16, 17 and impairments of diastolic function 18. Experiments in healthy men showed that a 30 minute exposure to SHS (e.g. the time of a meal) is sufficient for reduction of coronary flow velocity reserve 19 and sustained vascular injury characterized by mobilization of dysfunctional endothelial progenitor cells with blocked nitric oxide production and triggering of platelet aggregation in blood 15, 16, 20, 21. Chronic vascular effects of SHS start with endothelial dysfunction in children 22, arterial stiffness 23 and develop to thickening of intima-media 24 and atherosclerosis 25, 26. Combined effects of tobacco smoke with ambient air pollution have been detected 27, so that interactions have to be assumed also for SHS and ambient PM2.5. Complex interactions with nutrition are likely, especially in connection with diabetes. SHS is a risk factor for metabolic syndrome 28, 29, glucose intolerance 30, insulin resistance and the development of type 2 diabetes mellitus 31. A meta-analysis of 6 prospective cohort studies 32 concluded, that SHS increases the relative risk of new diabetes to 1.21 (95 % CI 1.07–1.38). Another meta-analysis on 7 prospective studies 31 found that the increase of the relative risk for developing type 2 diabetes from passive smoking was 1.33 (95% CI 1.20-1.46) and after adjustments for publication bias it was 1.27 (95%CI 1.16-1.40). After manifestation of diabetes vascular complications are increased by exposure to tobacco smoke.

Benefits of Smoke-Free Legislation

Most at risk for acute effects of SHS like myocardial infarction or stroke are patients with preexisting coronary or cerebrovascular diseases, which in turn are promoted by chronic exposure to SHS. Since Sargent et al. 33 published reduced incidence of admissions for myocardial infarction associated with a public smoking ban, numerous studies confirmed, that enforcement of smoke-free laws rapidly reduces admissions for acute coronary syndrome 34, 35, 36 and also other cardiac and cerebrovascular diseases 37. Smoke-free legislation is associated with a lower risk of hospitalization and death from CVD, significantly lower rates of hospital admissions or deaths from coronary events (relative risk, 0.85; 95%CI 0.82–0.88), other heart disease (relative risk, 0.61; 95%CI 0.44–0.85),and cerebrovascular accidents (relative risk, 0.84; 95%CI 0.75–0.94). More comprehensive laws were associated with larger changes in risk 37. Indoor smoking bans reduced myocardial infarction up to 33-40% 33, 38 and in most studies by 10-20%, in the first year mainly associated with the elimination of passive smoking and followed by sustainable decreases of coronary syndrome, myocardial infarction, stroke and incident diabetes also in ex-smokers 37, 39, 40, 41, 42. With a smoke-free hospitality industry people recognized tobacco smoke as an air pollutant, smoking in public was denormalized and social acceptance of smoking in front of children and pregnant women decreased also in homes and in cars 43, 44, 45, 46, 47. A meta-analysis came to the conclusion that public smoking bans (workplaces including the hospitality industry) reduced children’s exposure to SHS at home by 28% 48. Therefore it is not surprising that enforcement of smoke-free legislation was also followed by a 10% reduction in preterm birth and hospital admissions of children with asthma 49.

Dose-Response Relationships for SHS and CVD

Substantial and rapid reaction of the cardiovascular system (platelet and endothelial function, arterial stiffness, atherosclerosis, oxidative stress, inflammation, heart rate variability, energy metabolism, and increased infarct size) explains why SHS increases the risk of coronary heart disease by about 30% 50. Cardiovascular risks have been underestimated in many studies by comparison of active smokers with non-smokers, of which a large part was exposed to SHS 51. There is evidence of a strong, consistent and dose-dependent association between exposure to secondhand smoke and risk of myocardial infarction and stroke, suggestive of a causal relationship, with disproportionately high risk at low levels of exposure suggesting no safe lower limit of exposure for risk groups 10, 11. Chronic exposure of persons, which are healthy at beginning of exposure, is associated with a continuous increase of risk of CVD over the years. Already Whincup et al. 52 were able to show, that in male, light and heavy passive smokers, classified by serum cotinine at beginning of follow up, major coronary heart disease increased by years of follow up. The increase in heavy passive smokers was comparable to the increase in light active smokers. In a European cohort a hazard ratio of 1.25 (95%CI 1.04-1.50) was calculated for passive smoking (verified in a subsample by plasma cotinine) per each additional daily hour of exposure 53. A meta-analysis on health effects of SHS found a relative risk of 1.35 (95 % CI: 1.22-1.50) for stroke and 1.27 (95 % CI: 1.10-1.48) for ischemic heart disease 54. The risks were higher in women. Flores et al. 55 proved that the premature mortality hazard of recalled and unconscious exposure to SHS is comparable and predicted by serum cotinine at beginning of observation. There was a significant trend in years of life lost, adjusted for confounders, across cotinine categories both in non-smokers (P < 0.0001) and non-smokers reporting no SHS exposure (P = 0.002).

SHS Effects in Children and Unborn

The younger the child the more vulnerable it seems to be, especially for SHS effects on brain and lungs, but also CVD 56, 57. Recently a meta-analysis on parental smoking and the risk of congenital heart defects concluded, that maternal active smoking was significantly associated with risk of atrial septal defect and right ventricular outflow tract obstruction and that also maternal passive smoking as well as paternal smoking increased the risk of congenital heart defects in offspring 58. Many effects of prenatal exposure to tobacco smoke have been attributed to nicotine 59, with adverse perinatal outcomes associated to placental syndromes 60 and direct toxic effects on arteries supplying the fetus 61, 62 and his heart 63, 64. Prenatal exposure to constituents of tobacco smoke can also have long lasting effects on children and only few epidemiological studies were able to disentangle them from effects of postnatal exposure 65, 66.

Third Hand Smoke (THS, “Cold Smoke”)

SHS leaves accumulating contaminants on surfaces like carpets, wallpapers, upholstery, blankets or soft toys and these remnants endanger in particular children by oral, dermal and inhalation uptake from house dust, etc.. Even parents omitting contamination of indoor air nevertheless bring toxins and carcinogens to indoor spaces and to their children by clothes, hair, skin and breath, but the highest contamination is found on surfaces of rooms used for smoking. From these surfaces toxins are released back into the air and by aging and chemical transformations more toxic pollutants are formed, e.g. residual nicotine from tobacco smoke sorbed to indoor surfaces reacts with ambient nitrous acid to form carcinogenic nitrosamines 67, 68, 69. Animal experiments demonstrated numerous effects of THS: hyperactivity, persistent changes in the immune and hematopoietic system, lung cancer, liver damage, increased thrombogenesis, and metabolic effects, including elevated triglycerides, increased LDL, decreased HDL, and insulin resistance through oxidative stress 69, 70, 71, 72. Estimates of harm from THS are all by inference, since direct evidence of human health problems arising from THS is not available.

Cardiovascular Risks of Passive Exposure to Emissions of Water Pipe, Heated Tobacco and Electronic Cigarettes

Water pipe (shisha) produces similar risks for bystanders as tobacco cigarettes, but concentrations of carbon monoxide and heavy metals are higher in SHS from shisha. Depending on intensity and duration of passive exposure similar CVDs could develop as proven for active consumption, while acute cardiovascular effects on risk groups are expected mainly from fine particulate matter, carbon monoxide and nicotine 73, 74, 75. Animal experiments showed hypercoagulability, inflammation, as well as systemic and cardiac oxidative stress 76.

Heated tobacco products (HTPs) are marketed as less dangerous than conventional cigarettes because of less products of pyrolysis, however, biomarkers of potential cardiovascular harm did not support this claim 77. HTPs impair vascular endothelial function measured by arterial flow-mediated dilatation in rats to the same extent as by cigarette smoke 78. An advantage of electronic devices over conventional cigarettes is that SHS is only produced when the user exhales the aerosols and not continuously like in conventional smoking released from the burning end of cigarettes between puffs. The doses calculated for SHS uptake from electronic devices were significantly lower, below 1.6×108particles/kg bodyweight, than those due to combustion devices, but dosimetry estimates were 50% to 110% higher for HTPs than for e-cigarettes 79. The carrier function of aerosols from e-cigarettes might be similar, but the clearance of liquid particles is certainly faster than of solid particles released by conventional cigarettes. On the other hand, harmful volatile organic compounds, tobacco-specific nitrosamines and heavy metals in electronic cigarettes can be even higher in e-cigarettes than in traditional cigarettes 80.

Electronic cigarettes have been called “wolf in sheep’s clothing”, because they may serve as a gateway drug for youth, prolong nicotine addiction and the ritual in smokers who would otherwise be willing to quit and keep up the handling and use of cigarettes in public 81. Exposure of bystanders to products of pyrolysis are lower than in passive smoking, but exposure to nicotine is similar and particles in the aerosol are smaller 82, 83, 84, 85. Aerosols exhaled during vaping are less persistent than SHS, nevertheless they are carriers for toxins, which they adsorb on their large surface and transport them into the depth of the lung, where clearance is less efficient 81. Contamination of neighboring rooms was found 86 and it has to be assumed that also passive vaping increases cardiovascular risks, which were found for active vaping 87, 88. Though exposure to nano-particles is not as high as in passive exposure to heated tobacco, the combination of ultrafine particles with nicotine and other toxins has to be regarded as a respiratory 89 and cardiovascular risk, which is avoidable 90. For smoking cessation dermal and oral nicotine products from pharmacies are safer for nicotine replacement and do not contaminate the breathing air of bystanders 81. Most worrying are associations found recently between e-cigarette use and myocardial infarction 91.

Funding

This research received no external funding

References

  1. 1.World Health. (2012) Organisation, World Heart Federation. Cardiovascular harms from tobacco use and secondhand smoke: Global gaps in awareness and implications for action. , Waterloo, Ontario, Canada and Geneva
  1. 2.Banks E, Joshy G, Weber M F, Liu B, Grenfell R et al.Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence.
  1. 3.Drope J, Schluger N, Cahn Z, Drope J. (2018) . The Tobacco Atlas. 6th ed. American Cancer Society and Vital Strategies Hamill S, Islami F, Liber A, Nargis N, Stoklosa M , Atlanta .
  1. 4.Zhang X, Shu X O, Yang G, Li H L, Xiang Y B et al. (2005) Association of passive smoking by husbands with prevalence of stroke among Chinese women nonsmokers. , Am J Epidemiol
  1. 5.Chen Z, Peto R, Zhou M, Iona A, Smith M et al.Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies.
  1. 6.Health World.Organisation, Western Pacific Region. Tobacco in China. http://www.wpro.who.int/china/mediacentre/factsheets/tobacco/en/ (accessed on 2.4.2019)
  1. 7.Oberg M, Jaakkola M S, Woodward A, Peruga A, Prüss-Ustün A. (2011) Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 377(9760), 139-46.
  1. 8.Colditz GA Kawachi, Speizer F E, Manson J E, Stampfer M J, Willett W C et al. (1997) A Prospective Study of Passive Smoking and Coronary Heart Disease. Circulation. 95(10), 2374-9.
  1. 9.Nishino Y, Tsuji I, Tanaka H, Nakayama T, Nakatsuka H et al. (2014) Stroke mortality associated with environmental tobacco smoke among never-smoking Japanese women: A prospective cohort study. Prev Med. 67, 41-5.
  1. 10.Oono I P, Mackay D F, Pell J P. (2011) Meta-analysis of the association between secondhand smoke exposure and stroke. , J Public Health (Oxf) 33(4), 496-502.
  1. 11.Neuberger M. (2008) Feinstaub und akutes Koronarsyndrom. Universum Innere Medizin. https://www.aerzteinitiative.at/UnivInnereMed08.pdf (accessed on 2.4.2019) 01, 90-2.
  1. 12.Nowak D, Raupach T, Radon K, Andreas S. (2008) Passivrauchen als Gesundheitsrisiko. Der Pneumologe. 5(6), 386-92.
  1. 13.Invernizzi G, Ruprecht A, Mazza R, Rossetti E, SascoA NardiniS et al. (2004) Particulate matter from tobacco versus diesel car exhaust: an educational perspective. Tob Control. 13(3), 219-21.
  1. 14.Hamer M, Stamatakis E, Kivimaki M, Lowe G D, Batty G D. (2010) Objectively Measured Secondhand Smoke Exposure and Risk of Cardiovascular Disease. , J Am Coll Cardiol 56(1), 18-23.
  1. 15.Raupach T, Schäfer K, Konstantinides S, Andreas S. (2006) Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 27(4), 386-92.
  1. 16.Frey P F, Ganz P, Hsue P Y, Benowitz N L, Glantz S A et al. (2012) The Exposure-Dependent Effects of Aged Secondhand Smoke on Endothelial Function. , J Am Coll Cardiol 59(21), 1908-13.
  1. 17.Venn A, Britton J. (2007) Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults. Circulation. 115(8), 990-5.
  1. 18.Dogan A, Yarlioglues M, Gul I, Kaya M G, Ozdogru I et al. (2011) Acute effects of passive smoking on left ventricular systolic and diastolic function in healthy volunteers. , J Am Soc Echocardiogr 24(2), 185-91.
  1. 19.Otsuka R, Watanabe H, Hirata K, Tokai K, Muro T et al. (2001) Acute Effects of Passive Smoking on the Coronary Circulation in Healthy Young Adults. JAMA. 286(4), 436-41.
  1. 20.Heiss C, Amabile N, Lee A C, Real W M, Schick S F et al. (2008) Brief Secondhand Smoke Exposure Depresses Endothelial Progenitor Cells Activity and Endothelial Function. , J Am Coll Cardiol 51(18), 1760-71.
  1. 21.Pechacek T F. (2004) Babb S.How acute and reversible are the cardiovascular risks of secondhand smoke? BMJ. 328(7446), 980-3.
  1. 22.Kallio K, Jokinen E, Raitakari O T, Hämäläinen M, Siltala M et al. (2007) Tobacco Smoke Exposure Is Associated With Attenuated Endothelial Function in 11-Year-Old Healthy Children. Circulation. 115(25), 3205-12.
  1. 23.Doonan R J, Hausvater A, Scallan C, Mikhailidis D P, Pilote L et al. (2010) The effect of smoking on arterial stiffness. Hypertens Res. 33(5), 398-410.
  1. 24.Kallio K, Jokinen E, Saarinen M, Hämäläinen M, Volanen I et al. (2010) Arterial Intima-Media Thickness, Endothelial Function, and Apolipoproteins in Adolescents Frequently Exposed to Tobacco Smoke. Circ Cardiovasc Qual Outcomes. 3(2), 196-203.
  1. 25.Knoflach M, Kiechl S, Penz D, Zangerle A, Schmidauer C et al. (2009) Cardiovascular Risk Factors and Atherosclerosis in Young Women. Stroke. 40(4), 1063-9.
  1. 26.F1 Peinemann, Moebus S, Dragano N, Möhlenkamp S, Lehmann N et al. (2011) Secondhand Smoke Exposure and Coronary Artery Calcification among Nonsmoking Participants of a Population-Based Cohort. Environ Health Perspect. 119(11), 1556-61.
  1. 27.Turner M C, Cohen A, Burnett R T, Jerrett M, Diver W R et al. (2017) Interactions between cigarette smoking and ambient PM2.5 for cardiovascular mortality. , Environ Res 154, 304-310.
  1. 28.Xie B, Palmer P H, Pang Z, Sun P, Duan H et al. (2010) Environmental tobacco use and indicators of metabolic syndrome in Chinese adults. Nicotine Tob Res. 12(3), 198-206.
  1. 29.Pagani L S, Nguyen A K, Fitzpatrick C. (2016) Prospective Associations Between Early Long-Term Household Tobacco Smoke Exposure and Subsequent Indicators of Metabolic Risk at Age 10. Nicotine Tob Res. 18(5), 1250-7.
  1. 30.Houston T K, Person S D, Pletcher M J, Liu K, Iribarren C et al. (2006) Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ. 332(7549), 1064-9.
  1. 31.Wei X, M E, Yu S. (2015) A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus. Diabetes Res Clin Pract. 107(1), 9-14.
  1. 32.Sun K, Liu D, Wang C, Ren M, Yang C et al. (2014) Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies. Endocrine. 47(2), 421-7.
  1. 33.Sargent R P, Shepard R M, Glantz S A. (2004) Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 328(7446), 977-80.
  1. 34.Pell J P, Haw S, Cobbe S, Newby D E, Pell A C et al. (2008) Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome. , N Engl J Med 359(5), 482-91.
  1. 35.Meyers D G, Neuberger J S. (2008) Cardiovascular effect of bans on smoking in public places. , Am J Cardiol 102(10), 1421-4.
  1. 36.Lightwood J M, Glantz S A. (2009) Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 120(14), 1373-9.
  1. 37.Tan C E, Glantz S A. (2012) Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation. 126(18), 2177-83.
  1. 38.Hurt R D, Weston S A, Ebbert J O, McNallan S M, Croghan I T et al. (2012) Myocardial Infarction and Sudden Cardiac Death in Olmsted County, Minnesota, Before and After Smoke-Free Workplace Laws. Arch Intern Med. 172(21), 1635-41.
  1. 39.Akter S, Okazaki H, Kuwahara K, Miyamoto T, Murakami T et al. (2015) . Smoking, Smoking Cessation, and the Risk of Type 2 Diabetes among Japanese Adults: Japan Epidemiology Collaboration on Occupational Health Study. PLoS One 10(7), 0132166.
  1. 40.Kabir Z, Connolly G N, Clancy L, Koh H K, Capewell S. (2008) Coronary heart disease deaths and decreased smoking prevalence in. , Massachusetts,(1993-2003),Am J Public Health 98(8), 1468-9.
  1. 41.Cronin E M, Kearney P M, Kearney P P, Sullivan P, Perry I J. (2012) CHAIR Working Group. Impact of a National Smoking Ban on Hospital Admission for Acute Coronary Syndromes: A Longitudinal Study. Clin Cardiol,35(4),205-9.
  1. 42.Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. (2013) Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national irish smoking ban: interrupted time-series analysis. , PLoS One 8(4), 62063.
  1. 43.Ferketich A K, Lugo A, La Vecchia C, Fernandez E, Boffetta P et al. (2016) Relation between national-level tobacco control policies and individual-level voluntary home smoking bans in Europe. Tob Control. 25(1), 60-5.
  1. 44.Mons U, Nagelhout G E, Allwright S, Guignard R, Putte B van den et al. (2013) Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control. 22(1), 2-9.
  1. 45.Holliday J C, Moore G F, Moore L A. (2009) Changes in child exposure to secondhand smoke after implementation of smoke-free legislation in Wales: a repeated cross-sectional study. , BMC Public Health 9-430.
  1. 46.Akhtar P C, Haw S J, Currie D B, Zachary R, Currie C E. (2009) Smoking restrictions in the home and secondhand smoke exposure among primary schoolchildren before and after introduction of the Scottish smoke-free legislation. Tob Control. 18(5), 409-15.
  1. 47.Martínez-Sánchez J M, Blanch C, Fu M, Gallus S, La Vecchia C et al. (2014) Do smoke-free policies in work and public places increase smoking in private venues? Tob Control,23(3),204-7.
  1. 48.Nanninga S, Lhachimi S K, Bolte G. (2018) Impact of public smoking bans on children’s exposure to tobacco smoke at home: a systematic review and meta-analysis. , BMC Public Health 18(1), 749.
  1. 49.Been J V, Nurmatov U B, Cox B, Nawrot T S, van Schayck CP et al. (2014) Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet. 383(9928), 1549-60.
  1. 50.Barnoya J, Glantz S A. (2005) Cardiovascular Effects of Secondhand Smoke: nearly as large as smoking. Circulation. 111(20), 2684-98.
  1. 51.Bonita R, Duncan J, Truelsen T, Jackson R T, Beaglehole R. (1999) Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control. 8(2), 156-60.
  1. 52.Whincup P H, Gilg J A, Emberson J R, Jarvis M J, Feyerabend C et al. (2004) Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement.BMJ,329(7459),200-5.
  1. 53.Gallo V, Neasham D, Airoldi L, Ferrari P, Jenab M et al. (2010) Second-hand smoke, cotinine levels, and risk of circulatory mortality in a large cohort study of never-smokers. Epidemiology. 21(2), 207-14.
  1. 54.Fischer F, Kraemer A. (2015) Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke. , BMC Public Health 15, 1202.
  1. 55.Flores R M, Liu B, Taioli E. (2016) Association of serum cotinine levels and lung cancer mortality in non-smokers. Carcinogenesis. 37(11), 1062-9.
  1. 56.Horak F, Fazekas T, Zacharasiewicz A, Eber E, Kiss H et al. (2012) The Fetal Tobacco Syndrome. Wien Klin Wochenschr. 124, 129-45.
  1. 57.Neuberger M. (2018) Innenluft und Passivrauch. Der Pneumologe. 15(4), 254-62.
  1. 58.Zhao L, Chen L, Yang T, Wang L, Wang T et al. (2019) Parental smoking and the risk of congenital heart defects in offspring: An updated meta-analysis of observational studies. https://doi.org/10.1177/2047487319831367 (accessed on 2.4.2019) , Eur J Prev Cardiol
  1. 59.Ginzel K H, Maritz G S, Marks D F, Neuberger M, Pauly J R et al. (2007) Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol. 12(2), 215-24.
  1. 60.Aliyu M H, Lynch O, Wilson R E, Alio A P, Kristensen S et al. (2011) Association between tobacco use in pregnancy and placenta-associated syndromes: a population-based study. Arch Gynecol Obstet. 283(4), 729-34.
  1. 61.Geelhoed J, H el Marroun, Verburg B, L van Osch‐Gevers, Hofman A et al. (2011) Maternal smoking during pregnancy, fetal arterial resistance adaptations and cardiovascular function in childhood. , BJOG; 118, 755-62.
  1. 62.Rua Ede A, Porto M L, Ramos J P, Nogueira B V, Meyrelles S S et al. (2014) Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates. , J Biomed Sci 21-105.
  1. 63.Kapaya H, Broughton-Pipkin F, Hayes-Gill B, Loughna P V. (2015) Smoking in pregnancy affects the fetal heart: possible links to future cardiovascular disease. , J Matern Fetal Neonatal Med 28(14), 1664-8.
  1. 64.Lee L J, Lupo P J. (2013) Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: a systematic review and metaanalysis. Pediatr Cardiol. 34(2), 398-407.
  1. 65.Pattenden S, Antova T, Neuberger M, Nikiforov B, M De Sario et al. (2006) Parental smoking and children’s respiratory health: independent effects of prenatal and postnatal exposure. Tobacco Control. 15(4), 294-301.
  1. 66.Zhang K, Wang X. (2013) Maternal smoking and increased risk of sudden infant death syndrome: a meta-analysis. Leg Med (Tokyo). 15(3), 115-21.
  1. 67.Schick S F, Farraro K F, Perrino C, Sleiman M, Vossenberg G van de et al. (2014) Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK. Tob Control. 23(2), 152-9.
  1. 68.Matt G E, PJE Quintana, Zakarian J M, Hoh E, Hovell M F et al. (2016) When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution. Tob Control. 26(5), 548-56.
  1. 69.Jacob P 3rd, Benowitz N L, Destaillats H, Gundel L, Hang B et al. (2017) Thirdhand Smoke: New Evidence, Challenges, and Future Directions. Chem Res Toxicol. 30(1), 270-94.
  1. 70.Martins-Green M, Adhami N, Frankos M, Valdez M, Goodwin B et al. (2014) Cigarette smoke toxins deposited on surfaces: implications for human health. PLoS One. 9(1), 86391.
  1. 71.Hang B, Snijders A M, Huang Y, Schick S F, Wang P et al. (2017) Early exposure to thirdhand cigarette smoke affects body mass and the development of immunity in mice. Sci Rep. 7, 41915.
  1. 72.Hang B, Wang Y, Huang Y, Wang P, Langley S A et al. (2018) Short-term early exposure to thirdhand cigarette smoke increases lung cancer incidence in mice. Clin Sci (Lond). 132(4), 475-88.
  1. 73.Kumar S R, Davies S, Weitzman M, Sherman S.A review of air quality, biological indicators and health effects of second-hand waterpipe smoke exposure. Tob Control 2015; 24 Suppl 1:i54-i59. https://tobaccocontrol.bmj.com/content/24/Suppl_1/i54
  1. 74.Platt D E, Hariri E, Salameh P, Helou M, Sabbah N et al. (2017) Association of waterpipe smoking with myocardial infarction and determinants of metabolic syndrome among catheterized patients. Inhal Toxicol. 29(10), 429-34.
  1. 75.Waziry R, Jawad M, Ballout R A, Al Akel M, Akl E A. (2017) The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. , Int 46(1), 32-43.
  1. 76.Nemmar A, Al-Salam S, Beegam S, Yuvaraju P, Oulhaj A et al. (2017) . Water-Pipe Smoke Exposure-Induced Circulatory Disturbances in Mice, and the Influence of Betaine Supplementation Thereon. Cell Physiol Biochem 41, 1098-1112.
  1. 77.Glantz S A. (2018) PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control. Nov;27(Suppl 1):s9-s12
  1. 78.Nabavizadeh P, Liu J, Havel C M, Ibrahim S, Derakhshandeh R et al.Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control 2018; 27(Suppl 1):. 13-19.
  1. 79.Protano C, Manigrasso M, Avino P, Vitali M. (2017) Second-hand smoke generated by combustion and electronic smoking devices used in real scenarios: Ultrafine particle pollution and age-related dose assessment. , Environ Int 107, 190-5.
  1. 80.Zhang G, Wang Z, Zhang K, Hou R, Xing C et al. (2018) Safety Assessment of Electronic Cigarettes and Their Relationship with Cardiovascular Disease. , Int J Environ Res Public Health 15(1), 15-75.
  1. 81.Neuberger M. (2015) The electronic cigarette: a wolf in sheep's clothing. , Wien Klin Wochenschr 127(910), 385-7.
  1. 82.Ballbè M, Martínez-Sánchez J M, Sureda X, Fu M, Pérez-Ortuño R et al. (2014) Cigarettes vs. e-cigarettes: Passive exposure at home measured by means of airborne marker and biomarkers. , Environ Res 135, 76-80.
  1. 83.Johnson J M, Naeher L P, Yu X, Rathbun S L, Muilenburg J L et al. (2018) Air monitoring at large public electronic cigarette events. , Int J Hyg Environ Health 221(3), 541-7.
  1. 84.Fuoco F C, Buonanno G, Stabile L, Vigo P. (2014) Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. , Environ Pollut 184, 523-9.
  1. 85.Schripp T, Markewitz D, Uhde E, Salthammer T. (2013) Does e-cigarette consumption cause passive vaping? Indoor Air. 23(1), 25-31.
  1. 86.Khachatoorian C, Jacob Iii P, Benowitz N L, Talbot P. (2018) Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building. Tob Control. 2018-054316.
  1. 87.Glantz S A, Bareham D W. (2018) E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications. Annu Rev Public Health. 39, 215-35.
  1. 88.Alzahrani T, Pena I, Temesgen N, Glantz S A. (2018) Association Between Electronic Cigarette Use and Myocardial Infarction. , Am J Prev Med 55(4), 455-61.
  1. 89.Ratajczak A, Feleszko W, Smith D M, Goniewicz M. (2018) How close are we to definitively identifying the respiratory health effects of e-cigarettes? Expert Rev Respir Med. 12(7), 549-56.
  1. 90.Schober W, Fembacher L, Frenzen A, Fromme H. (2019) Passive exposure to pollutants from conventional cigarettes and new electronic smoking devices (IQOS, e-cigarette) in passenger cars. , Int J Hyg Environ Health 222(3), 486-493.
  1. 91.Bhatta D, Glantz S. (2019) Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health, J Am Heart Assoc, https://www.ahajournals.org/doi/10.1161/JAHA.119.012317. accessed on 08.06.2019.

Cited by (4)

  1. 1.Neuberger Manfred, 2021, , , (), 1, 10.1007/978-3-642-36206-4_124-1
  1. 2.Neuberger Manfred, 2021, Tobacco, Nicotine and Health, Medicina, 57(8), 740, 10.3390/medicina57080740
  1. 3.Berger Julia, Neuberger Manfred, Cheng Qiang, 2020, Occupational and Environmental Health Benefits of Smoking ban not yet Arrived in Austrian Youth, International Journal of Occupational and Environmental Medicine, 1(2), 1, 10.14302/issn.2690-0904.ijoe-20-3205
  1. 4.Neuberger Manfred, 2021, , , (), 1127, 10.1007/978-3-030-57499-4_124